Evaluation of the 177mLu-concentration in in-house produced 177Lu-radiopharmaceuticals and commercially available Lutathera®

Evaluation of the 177mLu-concentration in in-house produced 177Lu-radiopharmaceuticals and commercially available Lutathera®

Abstract Background 177Lu-radiopharmaceuticals can contain the metastable impurity [177mLu]lutetium with a physical half-life of 160.4 days, in varying concentrations depending on the route of production of the radionuclidic precursor [177Lu]lutetium. Due to the long half-life of [177mLu]lutetium, d...

Full description

Bibliographic Details
Main Authors: Matthias Balzer, Fleur Spiecker, Stephanie Bluemel, Holger Amthauer, Winfried Brenner, Sarah Spreckelmeyer
Format: Article
Language:English
Published: SpringerOpen 2023-11-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
Lutetium-177 m
Radionuclidic impurities
Metastable
Long-lived
Radiopharmaceutical quality control
Waste management
Online Access:https://doi.org/10.1186/s41181-023-00222-2

Internet

https://doi.org/10.1186/s41181-023-00222-2

Similar Items